

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | response to peptidoglycan (GO:0032494) | 5.43103810 |
| 2 | negative regulation of interleukin-12 production (GO:0032695) | 5.25306014 |
| 3 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.17360522 |
| 4 | negative regulation of cell killing (GO:0031342) | 5.17360522 |
| 5 | neutrophil activation involved in immune response (GO:0002283) | 5.08173447 |
| 6 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.98708251 |
| 7 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.97884041 |
| 8 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.97884041 |
| 9 | modulation by symbiont of host immune response (GO:0052553) | 4.97884041 |
| 10 | positive regulation by symbiont of host defense response (GO:0052509) | 4.97884041 |
| 11 | modulation by symbiont of host defense response (GO:0052031) | 4.97884041 |
| 12 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.97884041 |
| 13 | regulation of T cell tolerance induction (GO:0002664) | 4.67281158 |
| 14 | macrophage activation involved in immune response (GO:0002281) | 4.65305575 |
| 15 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 4.55221036 |
| 16 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.54683440 |
| 17 | production of molecular mediator involved in inflammatory response (GO:0002532) | 4.52297340 |
| 18 | positive regulation of type 2 immune response (GO:0002830) | 4.49544235 |
| 19 | regulation of T-helper 1 cell differentiation (GO:0045625) | 4.47265309 |
| 20 | detection of other organism (GO:0098543) | 4.44117591 |
| 21 | regulation of tolerance induction (GO:0002643) | 4.28513912 |
| 22 | detection of bacterium (GO:0016045) | 4.17892524 |
| 23 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.10144200 |
| 24 | positive regulation of tolerance induction (GO:0002645) | 4.07635002 |
| 25 | immunoglobulin mediated immune response (GO:0016064) | 4.03484663 |
| 26 | detection of molecule of bacterial origin (GO:0032490) | 4.02692159 |
| 27 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.98876540 |
| 28 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.96405976 |
| 29 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.83711742 |
| 30 | detection of external biotic stimulus (GO:0098581) | 3.83402975 |
| 31 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.78510406 |
| 32 | T-helper 1 type immune response (GO:0042088) | 3.77507724 |
| 33 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.76850872 |
| 34 | positive regulation of antigen processing and presentation (GO:0002579) | 3.74513462 |
| 35 | neutrophil activation (GO:0042119) | 3.72809132 |
| 36 | granulocyte activation (GO:0036230) | 3.68433287 |
| 37 | leukocyte aggregation (GO:0070486) | 3.66557949 |
| 38 | regulation of antigen processing and presentation (GO:0002577) | 3.66242361 |
| 39 | cellular response to type I interferon (GO:0071357) | 3.61386901 |
| 40 | type I interferon signaling pathway (GO:0060337) | 3.61386901 |
| 41 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 3.58685370 |
| 42 | response to type I interferon (GO:0034340) | 3.56711770 |
| 43 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.55018521 |
| 44 | cellular extravasation (GO:0045123) | 3.54187651 |
| 45 | regulation of interleukin-12 production (GO:0032655) | 3.53994520 |
| 46 | defense response to protozoan (GO:0042832) | 3.52290965 |
| 47 | regulation of gamma-delta T cell activation (GO:0046643) | 3.49884525 |
| 48 | regulation of type 2 immune response (GO:0002828) | 3.45861502 |
| 49 | response to host immune response (GO:0052572) | 3.43364904 |
| 50 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.43364904 |
| 51 | detection of biotic stimulus (GO:0009595) | 3.43187847 |
| 52 | regulation of mast cell degranulation (GO:0043304) | 3.42121273 |
| 53 | microglial cell activation (GO:0001774) | 3.41260173 |
| 54 | positive regulation of T-helper cell differentiation (GO:0045624) | 3.39116218 |
| 55 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.37056736 |
| 56 | myeloid cell activation involved in immune response (GO:0002275) | 3.34121425 |
| 57 | macrophage activation (GO:0042116) | 3.34024508 |
| 58 | dendritic cell chemotaxis (GO:0002407) | 3.32389920 |
| 59 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.31398647 |
| 60 | negative regulation of T cell mediated immunity (GO:0002710) | 3.29969509 |
| 61 | respiratory burst (GO:0045730) | 3.28658757 |
| 62 | response to muramyl dipeptide (GO:0032495) | 3.27848949 |
| 63 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.24983700 |
| 64 | response to protozoan (GO:0001562) | 3.24273770 |
| 65 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.22951186 |
| 66 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.20627325 |
| 67 | positive regulation of interleukin-10 production (GO:0032733) | 3.19316161 |
| 68 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.18737593 |
| 69 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 3.18288282 |
| 70 | positive regulation of interleukin-12 production (GO:0032735) | 3.17947611 |
| 71 | regulation of interferon-alpha production (GO:0032647) | 3.15250502 |
| 72 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.14673265 |
| 73 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 3.14594824 |
| 74 | regulation of T-helper cell differentiation (GO:0045622) | 3.13125589 |
| 75 | germinal center formation (GO:0002467) | 3.12321868 |
| 76 | B cell mediated immunity (GO:0019724) | 3.12165470 |
| 77 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 3.10771456 |
| 78 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.09209967 |
| 79 | response to host (GO:0075136) | 3.09209967 |
| 80 | response to host defenses (GO:0052200) | 3.09209967 |
| 81 | positive regulation of mast cell activation (GO:0033005) | 3.07570015 |
| 82 | regulation of interleukin-1 beta secretion (GO:0050706) | 3.07505796 |
| 83 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.07299123 |
| 84 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.06995699 |
| 85 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 3.06836865 |
| 86 | regulation of interleukin-10 production (GO:0032653) | 3.06599716 |
| 87 | positive regulation of interferon-alpha production (GO:0032727) | 3.06526866 |
| 88 | regulation of chronic inflammatory response (GO:0002676) | 3.04566760 |
| 89 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 3.03591716 |
| 90 | neutrophil mediated immunity (GO:0002446) | 3.02288510 |
| 91 | positive regulation of T-helper 1 type immune response (GO:0002827) | 3.00552223 |
| 92 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.99774832 |
| 93 | NIK/NF-kappaB signaling (GO:0038061) | 2.99585737 |
| 94 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.99585037 |
| 95 | regulation of mast cell activation (GO:0033003) | 2.98327082 |
| 96 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.98019342 |
| 97 | positive regulation of interleukin-17 production (GO:0032740) | 2.97702031 |
| 98 | regulation of leukocyte degranulation (GO:0043300) | 2.95214367 |
| 99 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.94084444 |
| 100 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.91651641 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.02502025 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.20235975 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.99965895 |
| 4 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.75395371 |
| 5 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.61762134 |
| 6 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.53208376 |
| 7 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.44090782 |
| 8 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.29574033 |
| 9 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.25539845 |
| 10 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.18225608 |
| 11 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.11724382 |
| 12 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.00804862 |
| 13 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.00192199 |
| 14 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.87259465 |
| 15 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.65804152 |
| 16 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.60419462 |
| 17 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.52631152 |
| 18 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.48302583 |
| 19 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.45991645 |
| 20 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.41872354 |
| 21 | SPI1_23127762_ChIP-Seq_K562_Human | 2.41377697 |
| 22 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.38797142 |
| 23 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.30791771 |
| 24 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.30549764 |
| 25 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.18239059 |
| 26 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.11586411 |
| 27 | VDR_24787735_ChIP-Seq_THP-1_Human | 2.04497318 |
| 28 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.02574600 |
| 29 | MAF_26560356_Chip-Seq_TH1_Human | 2.00810248 |
| 30 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.00016028 |
| 31 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.96281421 |
| 32 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.91192806 |
| 33 | MYB_26560356_Chip-Seq_TH2_Human | 1.88286710 |
| 34 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.88145457 |
| 35 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.87979023 |
| 36 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.75476256 |
| 37 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.74081420 |
| 38 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.73944802 |
| 39 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.67879025 |
| 40 | UTX_26944678_Chip-Seq_JUKART_Human | 1.63909587 |
| 41 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.59381729 |
| 42 | MYB_26560356_Chip-Seq_TH1_Human | 1.58530561 |
| 43 | GATA1_22025678_ChIP-Seq_K562_Human | 1.56764987 |
| 44 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.56568417 |
| 45 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.55726422 |
| 46 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.52124908 |
| 47 | MYC_22102868_ChIP-Seq_BL_Human | 1.50142542 |
| 48 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.46991769 |
| 49 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.44242894 |
| 50 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.42920912 |
| 51 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.40541790 |
| 52 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.39887463 |
| 53 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.37334693 |
| 54 | MAF_26560356_Chip-Seq_TH2_Human | 1.36655245 |
| 55 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.34351810 |
| 56 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.34293929 |
| 57 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.34054562 |
| 58 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.32116569 |
| 59 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.32097442 |
| 60 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.32021832 |
| 61 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.31447445 |
| 62 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.30604581 |
| 63 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.30098294 |
| 64 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.29316174 |
| 65 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.29047055 |
| 66 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.28986019 |
| 67 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.28250407 |
| 68 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.28051125 |
| 69 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.28008092 |
| 70 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.25939635 |
| 71 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.19277215 |
| 72 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.18204482 |
| 73 | GATA1_19941826_ChIP-Seq_K562_Human | 1.17471970 |
| 74 | GATA3_26560356_Chip-Seq_TH2_Human | 1.14214474 |
| 75 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.13128815 |
| 76 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.11601173 |
| 77 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.07787850 |
| 78 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.07723000 |
| 79 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.06876629 |
| 80 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.03640444 |
| 81 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.01894097 |
| 82 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.01236914 |
| 83 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.96976186 |
| 84 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.96462419 |
| 85 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.96386502 |
| 86 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.94573605 |
| 87 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.94005920 |
| 88 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.91507829 |
| 89 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.89161852 |
| 90 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.87337849 |
| 91 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.87149587 |
| 92 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.86086959 |
| 93 | GATA2_19941826_ChIP-Seq_K562_Human | 0.83462476 |
| 94 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.82436516 |
| 95 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.79395883 |
| 96 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.77486399 |
| 97 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.76792262 |
| 98 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.71937011 |
| 99 | KDM2B_26808549_Chip-Seq_K562_Human | 0.71405887 |
| 100 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.71091138 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003303_peritoneal_inflammation | 4.85837909 |
| 2 | MP0003724_increased_susceptibility_to | 4.49021259 |
| 3 | MP0003436_decreased_susceptibility_to | 3.95041418 |
| 4 | MP0001835_abnormal_antigen_presentation | 3.79512324 |
| 5 | MP0009785_altered_susceptibility_to | 3.48428609 |
| 6 | MP0006082_CNS_inflammation | 3.39182896 |
| 7 | MP0002148_abnormal_hypersensitivity_rea | 3.30109906 |
| 8 | MP0002419_abnormal_innate_immunity | 3.10958358 |
| 9 | MP0005671_abnormal_response_to | 3.00690759 |
| 10 | MP0005000_abnormal_immune_tolerance | 2.98619802 |
| 11 | MP0000685_abnormal_immune_system | 2.94579329 |
| 12 | MP0005025_abnormal_response_to | 2.91925223 |
| 13 | MP0001790_abnormal_immune_system | 2.90690592 |
| 14 | MP0005387_immune_system_phenotype | 2.90690592 |
| 15 | MP0001800_abnormal_humoral_immune | 2.70008772 |
| 16 | MP0002723_abnormal_immune_serum | 2.56277658 |
| 17 | MP0002452_abnormal_antigen_presenting | 2.54713007 |
| 18 | MP0003300_gastrointestinal_ulcer | 2.36894786 |
| 19 | MP0004510_myositis | 2.31553918 |
| 20 | MP0001819_abnormal_immune_cell | 2.27846664 |
| 21 | MP0002420_abnormal_adaptive_immunity | 2.26483940 |
| 22 | MP0001533_abnormal_skeleton_physiology | 2.17958934 |
| 23 | MP0005058_abnormal_lysosome_morphology | 2.15538724 |
| 24 | MP0009764_decreased_sensitivity_to | 2.05024788 |
| 25 | MP0003172_abnormal_lysosome_physiology | 1.98557738 |
| 26 | MP0003191_abnormal_cellular_cholesterol | 1.98386527 |
| 27 | MP0001845_abnormal_inflammatory_respons | 1.95572300 |
| 28 | MP0002405_respiratory_system_inflammati | 1.93390523 |
| 29 | MP0010155_abnormal_intestine_physiology | 1.92258833 |
| 30 | MP0009278_abnormal_bone_marrow | 1.90930562 |
| 31 | MP0004947_skin_inflammation | 1.88022591 |
| 32 | MP0003075_altered_response_to | 1.87644826 |
| 33 | MP0005451_abnormal_body_composition | 1.83419180 |
| 34 | MP0005464_abnormal_platelet_physiology | 1.77673856 |
| 35 | MP0008469_abnormal_protein_level | 1.68957828 |
| 36 | MP0000343_altered_response_to | 1.68339752 |
| 37 | MP0000716_abnormal_immune_system | 1.64820670 |
| 38 | MP0005310_abnormal_salivary_gland | 1.61205874 |
| 39 | MP0008260_abnormal_autophagy | 1.55493001 |
| 40 | MP0002398_abnormal_bone_marrow | 1.51389699 |
| 41 | MP0009333_abnormal_splenocyte_physiolog | 1.49811614 |
| 42 | MP0005397_hematopoietic_system_phenotyp | 1.46300700 |
| 43 | MP0001545_abnormal_hematopoietic_system | 1.46300700 |
| 44 | MP0002998_abnormal_bone_remodeling | 1.44296503 |
| 45 | MP0003690_abnormal_glial_cell | 1.37504906 |
| 46 | MP0003828_pulmonary_edema | 1.35564086 |
| 47 | MP0000858_altered_metastatic_potential | 1.35141124 |
| 48 | MP0003448_altered_tumor_morphology | 1.35040285 |
| 49 | MP0003806_abnormal_nucleotide_metabolis | 1.34615079 |
| 50 | MP0008004_abnormal_stomach_pH | 1.31602152 |
| 51 | MP0005166_decreased_susceptibility_to | 1.29697607 |
| 52 | MP0009840_abnormal_foam_cell | 1.27923243 |
| 53 | MP0002429_abnormal_blood_cell | 1.27581170 |
| 54 | MP0003763_abnormal_thymus_physiology | 1.24208813 |
| 55 | MP0001853_heart_inflammation | 1.23365187 |
| 56 | MP0000689_abnormal_spleen_morphology | 1.23310921 |
| 57 | MP0002722_abnormal_immune_system | 1.22390573 |
| 58 | MP0005167_abnormal_blood-brain_barrier | 1.20981830 |
| 59 | MP0003183_abnormal_peptide_metabolism | 1.16513987 |
| 60 | MP0002277_abnormal_respiratory_mucosa | 1.15026471 |
| 61 | MP0000604_amyloidosis | 1.14891067 |
| 62 | MP0000465_gastrointestinal_hemorrhage | 1.08513730 |
| 63 | MP0005164_abnormal_response_to | 1.07895947 |
| 64 | MP0002132_abnormal_respiratory_system | 1.06421874 |
| 65 | MP0003656_abnormal_erythrocyte_physiolo | 1.02920291 |
| 66 | MP0009763_increased_sensitivity_to | 1.01872094 |
| 67 | MP0004883_abnormal_blood_vessel | 1.01817141 |
| 68 | MP0003866_abnormal_defecation | 0.97004694 |
| 69 | MP0002332_abnormal_exercise_endurance | 0.94532154 |
| 70 | MP0003453_abnormal_keratinocyte_physiol | 0.93901720 |
| 71 | MP0002138_abnormal_hepatobiliary_system | 0.93482784 |
| 72 | MP0001851_eye_inflammation | 0.93130134 |
| 73 | MP0002254_reproductive_system_inflammat | 0.93071119 |
| 74 | MP0009765_abnormal_xenobiotic_induced | 0.91672845 |
| 75 | MP0002139_abnormal_hepatobiliary_system | 0.89778961 |
| 76 | MP0005390_skeleton_phenotype | 0.87864961 |
| 77 | MP0006054_spinal_hemorrhage | 0.83866642 |
| 78 | MP0000703_abnormal_thymus_morphology | 0.81153599 |
| 79 | MP0001663_abnormal_digestive_system | 0.80626216 |
| 80 | MP0003091_abnormal_cell_migration | 0.70285882 |
| 81 | MP0000920_abnormal_myelination | 0.69431727 |
| 82 | MP0008874_decreased_physiological_sensi | 0.68900892 |
| 83 | MP0003795_abnormal_bone_structure | 0.67656080 |
| 84 | MP0004808_abnormal_hematopoietic_stem | 0.67451040 |
| 85 | MP0003045_fibrosis | 0.61959173 |
| 86 | MP0000249_abnormal_blood_vessel | 0.61813391 |
| 87 | MP0001873_stomach_inflammation | 0.59639650 |
| 88 | MP0002933_joint_inflammation | 0.59349621 |
| 89 | MP0005319_abnormal_enzyme/_coenzyme | 0.58609168 |
| 90 | MP0003221_abnormal_cardiomyocyte_apopto | 0.55695382 |
| 91 | MP0000490_abnormal_crypts_of | 0.55586047 |
| 92 | MP0002693_abnormal_pancreas_physiology | 0.55524187 |
| 93 | MP0002166_altered_tumor_susceptibility | 0.52637961 |
| 94 | MP0000371_diluted_coat_color | 0.50773963 |
| 95 | MP0005076_abnormal_cell_differentiation | 0.50529123 |
| 96 | MP0002006_tumorigenesis | 0.47230329 |
| 97 | MP0000609_abnormal_liver_physiology | 0.47168551 |
| 98 | MP0005535_abnormal_body_temperature | 0.44849308 |
| 99 | MP0001542_abnormal_bone_strength | 0.42942788 |
| 100 | MP0005381_digestive/alimentary_phenotyp | 0.42514422 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 6.08582568 |
| 2 | Abnormality of macrophages (HP:0004311) | 5.93800124 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 5.89625038 |
| 4 | Recurrent abscess formation (HP:0002722) | 5.77925539 |
| 5 | Orchitis (HP:0100796) | 5.67698048 |
| 6 | Myositis (HP:0100614) | 5.57399666 |
| 7 | Optic neuritis (HP:0100653) | 5.56248354 |
| 8 | Retrobulbar optic neuritis (HP:0100654) | 5.56248354 |
| 9 | Stomatitis (HP:0010280) | 4.76761451 |
| 10 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.63270472 |
| 11 | Gastrointestinal infarctions (HP:0005244) | 4.42524707 |
| 12 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.36907431 |
| 13 | Abnormality of glycolipid metabolism (HP:0010969) | 4.36907431 |
| 14 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.36907431 |
| 15 | Mediastinal lymphadenopathy (HP:0100721) | 4.23000625 |
| 16 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.95149451 |
| 17 | Keratoconjunctivitis sicca (HP:0001097) | 3.94968488 |
| 18 | Chronic obstructive pulmonary disease (HP:0006510) | 3.66423312 |
| 19 | Obstructive lung disease (HP:0006536) | 3.66423312 |
| 20 | Keratoconjunctivitis (HP:0001096) | 3.62653752 |
| 21 | Recurrent fungal infections (HP:0002841) | 3.59664798 |
| 22 | Recurrent skin infections (HP:0001581) | 3.59155349 |
| 23 | Vasculitis (HP:0002633) | 3.45196503 |
| 24 | Increased cerebral lipofuscin (HP:0011813) | 3.42090212 |
| 25 | Meningitis (HP:0001287) | 3.33083932 |
| 26 | Hemoptysis (HP:0002105) | 3.29235364 |
| 27 | Loss of speech (HP:0002371) | 3.27427599 |
| 28 | Encephalitis (HP:0002383) | 3.23528407 |
| 29 | Pulmonary infiltrates (HP:0002113) | 3.16758761 |
| 30 | Amyloidosis (HP:0011034) | 3.15619844 |
| 31 | Urticaria (HP:0001025) | 3.08893384 |
| 32 | Gingivitis (HP:0000230) | 3.06599942 |
| 33 | Increased IgE level (HP:0003212) | 3.06061254 |
| 34 | Increased IgM level (HP:0003496) | 3.02694042 |
| 35 | Disinhibition (HP:0000734) | 2.95240077 |
| 36 | Dysostosis multiplex (HP:0000943) | 2.92775210 |
| 37 | Anorexia (HP:0002039) | 2.91123629 |
| 38 | Spontaneous hematomas (HP:0007420) | 2.90909696 |
| 39 | Chest pain (HP:0100749) | 2.90705728 |
| 40 | Episodic fever (HP:0001954) | 2.90546959 |
| 41 | Gangrene (HP:0100758) | 2.88600274 |
| 42 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.88539360 |
| 43 | Vacuolated lymphocytes (HP:0001922) | 2.88513117 |
| 44 | Recurrent cutaneous fungal infections (HP:0011370) | 2.80196379 |
| 45 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.80196379 |
| 46 | Arterial thrombosis (HP:0004420) | 2.79815111 |
| 47 | Systemic lupus erythematosus (HP:0002725) | 2.77822773 |
| 48 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.73338927 |
| 49 | Recurrent viral infections (HP:0004429) | 2.72995892 |
| 50 | Autoimmune thrombocytopenia (HP:0001973) | 2.70148015 |
| 51 | T lymphocytopenia (HP:0005403) | 2.70085317 |
| 52 | Leukocytosis (HP:0001974) | 2.69897152 |
| 53 | Petechiae (HP:0000967) | 2.66925781 |
| 54 | Increased serum ferritin (HP:0003281) | 2.64908363 |
| 55 | Abnormality of T cell number (HP:0011839) | 2.59123439 |
| 56 | Purpura (HP:0000979) | 2.51279912 |
| 57 | Hematochezia (HP:0002573) | 2.50354902 |
| 58 | Prolonged bleeding time (HP:0003010) | 2.49736711 |
| 59 | Cellulitis (HP:0100658) | 2.47694069 |
| 60 | Pulmonary embolism (HP:0002204) | 2.47064832 |
| 61 | Peritonitis (HP:0002586) | 2.38971123 |
| 62 | Gingival bleeding (HP:0000225) | 2.38848268 |
| 63 | Hypergammaglobulinemia (HP:0010702) | 2.38705867 |
| 64 | Abnormality of the pleura (HP:0002103) | 2.31953201 |
| 65 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.31583999 |
| 66 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.31583999 |
| 67 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.31583999 |
| 68 | Premature loss of primary teeth (HP:0006323) | 2.30969167 |
| 69 | Abnormality of iron homeostasis (HP:0011031) | 2.29766702 |
| 70 | Inflammation of the large intestine (HP:0002037) | 2.28861953 |
| 71 | Hepatosplenomegaly (HP:0001433) | 2.27759971 |
| 72 | Amaurosis fugax (HP:0100576) | 2.25180779 |
| 73 | Mutism (HP:0002300) | 2.25176530 |
| 74 | Polyneuropathy (HP:0001271) | 2.23210746 |
| 75 | Abnormality of the endocardium (HP:0004306) | 2.22246716 |
| 76 | Epistaxis (HP:0000421) | 2.22063366 |
| 77 | Hypochromic microcytic anemia (HP:0004840) | 2.19701517 |
| 78 | Colitis (HP:0002583) | 2.18445412 |
| 79 | Vertigo (HP:0002321) | 2.18416269 |
| 80 | Gastrointestinal inflammation (HP:0004386) | 2.17488119 |
| 81 | Mucopolysacchariduria (HP:0008155) | 2.16850496 |
| 82 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.16850496 |
| 83 | Hypochromic anemia (HP:0001931) | 2.11314880 |
| 84 | Malnutrition (HP:0004395) | 2.09630931 |
| 85 | Glomerulopathy (HP:0100820) | 2.09330929 |
| 86 | Abnormality of the pericardium (HP:0001697) | 2.08919353 |
| 87 | Osteomyelitis (HP:0002754) | 2.08518857 |
| 88 | Progressive neurologic deterioration (HP:0002344) | 2.07858583 |
| 89 | Hypertensive crisis (HP:0100735) | 2.07762707 |
| 90 | Granulocytopenia (HP:0001913) | 2.07311155 |
| 91 | Acne (HP:0001061) | 2.05292968 |
| 92 | Pustule (HP:0200039) | 2.03785244 |
| 93 | Chronic otitis media (HP:0000389) | 2.02736215 |
| 94 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.00406300 |
| 95 | Interstitial pulmonary disease (HP:0006530) | 1.99393383 |
| 96 | Keratitis (HP:0000491) | 1.98693090 |
| 97 | Abnormality of T cells (HP:0002843) | 1.97998044 |
| 98 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.96410120 |
| 99 | Sepsis (HP:0100806) | 1.94571591 |
| 100 | Autoimmune hemolytic anemia (HP:0001890) | 1.93438201 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 4.52790045 |
| 2 | TYK2 | 3.16805759 |
| 3 | IRAK4 | 3.07241054 |
| 4 | BLK | 3.02630708 |
| 5 | IRAK3 | 2.99099344 |
| 6 | MAP4K1 | 2.90207798 |
| 7 | CSK | 2.78593930 |
| 8 | MAP2K3 | 2.54536752 |
| 9 | MAP3K14 | 2.52794075 |
| 10 | GRK7 | 2.48466096 |
| 11 | PRPF4B | 2.43380792 |
| 12 | MATK | 2.35858792 |
| 13 | FGR | 2.32882509 |
| 14 | ERN1 | 2.30601142 |
| 15 | TAOK1 | 2.10153833 |
| 16 | TBK1 | 2.09955770 |
| 17 | JAK3 | 2.01377636 |
| 18 | MAP3K3 | 1.91852900 |
| 19 | IKBKE | 1.91338520 |
| 20 | ZAP70 | 1.90700080 |
| 21 | MAP3K11 | 1.86369495 |
| 22 | TAOK2 | 1.81928324 |
| 23 | TXK | 1.79238021 |
| 24 | FES | 1.75210917 |
| 25 | TNK2 | 1.64889339 |
| 26 | MAP3K13 | 1.60420131 |
| 27 | EPHB1 | 1.58513531 |
| 28 | IKBKB | 1.52289496 |
| 29 | JAK1 | 1.48978291 |
| 30 | SYK | 1.42815785 |
| 31 | SIK3 | 1.41411127 |
| 32 | HCK | 1.40313473 |
| 33 | JAK2 | 1.37562277 |
| 34 | LYN | 1.37320432 |
| 35 | MAP3K1 | 1.35885705 |
| 36 | BTK | 1.34094625 |
| 37 | GRK6 | 1.27888631 |
| 38 | DDR2 | 1.23175377 |
| 39 | BMPR2 | 1.21768074 |
| 40 | IRAK1 | 1.17876814 |
| 41 | CDC42BPA | 1.11806805 |
| 42 | KIT | 1.07480908 |
| 43 | IRAK2 | 1.06501508 |
| 44 | CSF1R | 1.03993645 |
| 45 | MARK3 | 1.02165590 |
| 46 | RIPK1 | 1.01514517 |
| 47 | LCK | 1.01467457 |
| 48 | TGFBR2 | 0.99323570 |
| 49 | KSR2 | 0.98296588 |
| 50 | TAOK3 | 0.97388600 |
| 51 | ADRBK2 | 0.91488474 |
| 52 | MOS | 0.89465249 |
| 53 | EPHA3 | 0.81319505 |
| 54 | YES1 | 0.78886999 |
| 55 | MAP3K5 | 0.78499923 |
| 56 | NME2 | 0.76620058 |
| 57 | TESK2 | 0.74862701 |
| 58 | STK10 | 0.74086411 |
| 59 | PDK1 | 0.70120075 |
| 60 | MARK2 | 0.70008700 |
| 61 | SIK2 | 0.69746359 |
| 62 | DAPK2 | 0.69709318 |
| 63 | FGFR4 | 0.68038715 |
| 64 | PDPK1 | 0.67866128 |
| 65 | CHUK | 0.65388570 |
| 66 | PRKD2 | 0.61446781 |
| 67 | ITK | 0.59222429 |
| 68 | ACVR1B | 0.59060507 |
| 69 | FYN | 0.52968949 |
| 70 | TEC | 0.50043456 |
| 71 | SIK1 | 0.48842083 |
| 72 | MAP3K6 | 0.46588436 |
| 73 | MAPK7 | 0.46298550 |
| 74 | HIPK2 | 0.45059600 |
| 75 | PIM1 | 0.44895279 |
| 76 | FGFR3 | 0.44124593 |
| 77 | RPS6KC1 | 0.42649762 |
| 78 | RPS6KL1 | 0.42649762 |
| 79 | PTK6 | 0.39696607 |
| 80 | MAP2K6 | 0.38867048 |
| 81 | DYRK1B | 0.37802725 |
| 82 | TYRO3 | 0.36127179 |
| 83 | RPS6KA6 | 0.33851024 |
| 84 | MAPK12 | 0.33652402 |
| 85 | PIM2 | 0.33548455 |
| 86 | ARAF | 0.33460289 |
| 87 | KSR1 | 0.32720589 |
| 88 | DYRK3 | 0.32246989 |
| 89 | ABL1 | 0.31480677 |
| 90 | TRIB3 | 0.31357441 |
| 91 | PRKCD | 0.29796623 |
| 92 | SGK3 | 0.28276140 |
| 93 | PRKCQ | 0.27903590 |
| 94 | MAPK4 | 0.26986586 |
| 95 | MAPKAPK2 | 0.26921946 |
| 96 | CAMKK2 | 0.25426788 |
| 97 | CLK1 | 0.24911371 |
| 98 | CDK6 | 0.24772323 |
| 99 | BMX | 0.24215075 |
| 100 | MAP2K4 | 0.23488811 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 2.94952046 |
| 2 | * Osteoclast differentiation_Homo sapiens_hsa04380 | 2.93908925 |
| 3 | Allograft rejection_Homo sapiens_hsa05330 | 2.88801168 |
| 4 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.80405138 |
| 5 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.78556046 |
| 6 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.61774697 |
| 7 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.35534199 |
| 8 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.25312569 |
| 9 | Tuberculosis_Homo sapiens_hsa05152 | 2.24107368 |
| 10 | Malaria_Homo sapiens_hsa05144 | 2.15107657 |
| 11 | African trypanosomiasis_Homo sapiens_hsa05143 | 2.13972129 |
| 12 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.13305482 |
| 13 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.12985381 |
| 14 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.11782847 |
| 15 | Legionellosis_Homo sapiens_hsa05134 | 2.01960764 |
| 16 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.98777759 |
| 17 | Asthma_Homo sapiens_hsa05310 | 1.95525452 |
| 18 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.94144817 |
| 19 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.88930952 |
| 20 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.84682771 |
| 21 | Other glycan degradation_Homo sapiens_hsa00511 | 1.79167777 |
| 22 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.77671135 |
| 23 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.76003959 |
| 24 | Pertussis_Homo sapiens_hsa05133 | 1.71063480 |
| 25 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.69259938 |
| 26 | Influenza A_Homo sapiens_hsa05164 | 1.68419899 |
| 27 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.65951320 |
| 28 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.63086091 |
| 29 | Measles_Homo sapiens_hsa05162 | 1.62487158 |
| 30 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.62314534 |
| 31 | Lysosome_Homo sapiens_hsa04142 | 1.57336334 |
| 32 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.56019707 |
| 33 | Viral myocarditis_Homo sapiens_hsa05416 | 1.53912159 |
| 34 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.51235051 |
| 35 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.49987054 |
| 36 | Phagosome_Homo sapiens_hsa04145 | 1.44190621 |
| 37 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.42339993 |
| 38 | Salmonella infection_Homo sapiens_hsa05132 | 1.39781058 |
| 39 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.38922846 |
| 40 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.34146409 |
| 41 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.33714567 |
| 42 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.28784210 |
| 43 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.26868227 |
| 44 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.25892913 |
| 45 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.19064551 |
| 46 | Hepatitis C_Homo sapiens_hsa05160 | 1.13494822 |
| 47 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.11857572 |
| 48 | Shigellosis_Homo sapiens_hsa05131 | 1.10529499 |
| 49 | Hepatitis B_Homo sapiens_hsa05161 | 1.09474367 |
| 50 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.03841374 |
| 51 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.96948351 |
| 52 | Apoptosis_Homo sapiens_hsa04210 | 0.91970040 |
| 53 | Amoebiasis_Homo sapiens_hsa05146 | 0.82987317 |
| 54 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.79650137 |
| 55 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.75661155 |
| 56 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.75315451 |
| 57 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.75215274 |
| 58 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.73337487 |
| 59 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.70485463 |
| 60 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.69902555 |
| 61 | Platelet activation_Homo sapiens_hsa04611 | 0.69655614 |
| 62 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.64385097 |
| 63 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.61768634 |
| 64 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.61622500 |
| 65 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.61523114 |
| 66 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.60776921 |
| 67 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.60679673 |
| 68 | Bladder cancer_Homo sapiens_hsa05219 | 0.60314153 |
| 69 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.57019064 |
| 70 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.56940577 |
| 71 | Endocytosis_Homo sapiens_hsa04144 | 0.54824867 |
| 72 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.54317236 |
| 73 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.51500003 |
| 74 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.51279637 |
| 75 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.47668074 |
| 76 | Prion diseases_Homo sapiens_hsa05020 | 0.46632439 |
| 77 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.45539774 |
| 78 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.44156459 |
| 79 | HTLV-I infection_Homo sapiens_hsa05166 | 0.42704246 |
| 80 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.42597065 |
| 81 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.41846555 |
| 82 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.41028207 |
| 83 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.37753542 |
| 84 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.36501103 |
| 85 | Insulin resistance_Homo sapiens_hsa04931 | 0.33489551 |
| 86 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.31977507 |
| 87 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.31592220 |
| 88 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.30258673 |
| 89 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.29973330 |
| 90 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.27974124 |
| 91 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.26041032 |
| 92 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.22997901 |
| 93 | Endometrial cancer_Homo sapiens_hsa05213 | 0.22236122 |
| 94 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.21929058 |
| 95 | Mineral absorption_Homo sapiens_hsa04978 | 0.20410744 |
| 96 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.19712958 |
| 97 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.19679610 |
| 98 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.19229198 |
| 99 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.18878581 |
| 100 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.16111918 |

